Celgene CorpAdd to My Watchlist

CELG:USNASDAQ GSIndustry: Medical-Biomedical/Gene
  • 87.15
  • 1.19  -1.35%
    Today's Change
  • 88.34
    Previous Close
  • Today
    52 Week Low - High
8:10 pm ET 7/31/2014
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding800 million
Market Cap$70 billion
Return on Equity ttm28.55%
Last DividendCELG:US does not pay a dividend
EPS: Year Actual ttm2.464
EPS: Year Est. 12/14 ttm3.676
EPS: Quarterly Actual 6/14 0.90
EPS: Quarterly Est. 9/14 0.95
Price/Earnings ttm35.38
Relative Price/Earnings2.013
Earnings Growth Rate3.55
Company Description
Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.
Revenue$6 billion
Net Income$1 billion
Total Assets$13 billion
Web Sitewww.celgene.com

Latest Headlines


Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

Sign In Now


Not Registered?

Get complete access to The Washington Post online - it's FREE!